Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 7, 2018

Primary Completion Date

November 23, 2023

Study Completion Date

October 1, 2025

Conditions

Cholangitis, SclerosingHepatitis, Autoimmune

Interventions

BIOLOGICAL

Orbcel-C

Selected Mesenchymal Stromal Cells derived from human umbilical cord

Trial Locations (1)

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham

All Listed Sponsors

collaborator

NHS Blood and Transplant

OTHER_GOV

lead

University of Birmingham

OTHER

NCT02997878 - Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH | Biotech Hunter | Biotech Hunter